Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Cutis marmorata telangiectatica congenita (CMTC) is a rare congenital vascular disorder historically known as Van Lohuizen syndrome. While it has been referred to by several descriptive names in medical literature, "Cutis marmorata telangiectatica congenita" is the modern, universally accepted term used by clinicians and international medical databases to ensure diagnostic consistency. What are the alternative names and synonyms for Cutis marmorata telangiectatica congenita? In medical literature, you may encounter several terms used to describe Cutis marmorata telangiectatica congenita.
1 people with Cutis marmorata telangiectatica congenita have shared their first-person experience on this question at DiseaseMaps.
TL;DR: Cutis marmorata telangiectatica congenita (CMTC) is a rare congenital vascular disorder historically known as Van Lohuizen syndrome. While it has been referred to by several descriptive names in medical literature, "Cutis marmorata telangiectatica congenita" is the modern, universally accepted term used by clinicians and international medical databases to ensure diagnostic consistency.
In medical literature, you may encounter several terms used to describe Cutis marmorata telangiectatica congenita. Because this condition was first described by the Dutch pediatrician Dr. C.H. Van Lohuizen in 1922, it is frequently referred to as Van Lohuizen syndrome. Other historical or descriptive synonyms that appear in older clinical journals include:
These terms were often used before the pathophysiology of Cutis marmorata telangiectatica congenita was fully understood. Today, these names are considered obsolete and are primarily found in historical medical texts or legacy patient records.
The variety of names for Cutis marmorata telangiectatica congenita reflects the evolution of dermatological classification. Early researchers named the condition based on its visual presentation—specifically the net-like (reticular) pattern of dilated veins on the skin. As clinical understanding shifted from purely descriptive terminology to identifying the underlying vascular anomalies, the medical community standardized the nomenclature. Using the official term Cutis marmorata telangiectatica congenita helps prevent confusion with other reticulated skin conditions, such as primary cutis marmorata (a benign, transient condition that disappears with warming) or Klippel-Trenaunay syndrome.
For research and insurance coding purposes, Cutis marmorata telangiectatica congenita is categorized under specific international identifiers. These codes are essential for patients when seeking specialized care or navigating health insurance:
Medical professionals currently prefer the term Cutis marmorata telangiectatica congenita exclusively. Using this standardized name is vital for clinical documentation, as it distinguishes the diagnosis from transient physiological mottling or other vascular malformations. At DiseaseMaps.org, where 55 community members have shared their experiences with this diagnosis, we advocate for using the official name to ensure that patients can easily connect with accurate clinical resources and peer support groups.
Medical Disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.